VEERHEALTH logo

Veerhealth Care Ltd

VEERHEALTH·BSE·
₹49.73▲ +0.04 (+0.08%)
Market Cap98.23 Cr
PE Ratio184.19
Volume45,661
Day High - Low49.74 - 48.25
52W High-Low52.00 - 16.92

Veerhealth Care Ltd (VEERHEALTH): company summary

The company's business has improved significantly, with annual revenue rising 94.8% and annual net profit increasing 38.5%.

Veerhealth Care Ltd (VEERHEALTH) is a micro-cap Healthcare company valued at ₹98 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move
Veerhealth Care Ltd last traded at ₹49.73, modestly up 0.08% on the day.
Financial performance
The company's business has improved significantly, with annual revenue rising 94.8% and annual net profit increasing 38.5%. However, the net profit margin narrowed to 1.7% from 2.3% in the prior year, and return on equity remained low at 2.4%. The latest quarter saw revenue surge 455.2% and net profit jump 412.5% compared to the same quarter a year earlier.
Valuation multiples
The stock trades at 184.2 times earnings, a premium to the Healthcare median of 32.0, 4.36 times book value.
Things to watch
The company's profit growth has slowed, with a 30.1% decline in 3-year profit CAGR and a 7.3% increase in 5-year profit CAGR. The net profit margin has fallen by 0.7 percentage points, and the company's return on capital employed is only 6.0%. The stock is 4.4% below its 52-week high.
Where it stands
Veerhealth Care Ltd has seen strong revenue growth, but profit growth has been inconsistent. The latest quarter showed a sharp rise in both revenue and net profit, but the net profit margin remains low. The stock is currently 4.4% below its 52-week high.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
4.1/10
Weak
Fair Value
Sign in to see
ROE
2.37%
Weak
P/E
184.19x
Expensive
Debt / Equity
0.20
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day₹48.25
₹49.74
52W₹16.92
₹52.00
DocStoX take

Supported by momentum (7.5) and risk (6.3), but held back by valuation (0.0). Momentum looks strong at 7.5, but that is offset by valuation at 0.0 and quality at 2.9. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
4.1
/10
Weak
Quality
Weak
ROE 2.4%
Valuation
Expensive
P/E 184.2×
Growth
Slow
Revenue +25.1% 5Y CAGR
Risk
Moderate
D/E 0.20
Momentum
Strong
94% of 52-week range

At a glance

Market Cap
₹98 Cr
52W High / Low
₹52 / ₹17
Dividend Yield
0.00%
Promoter Holding
31.91%
EPS (TTM)
₹0.27
Book Value
₹11.46

Key highlights

  • Low leverage — D/E 0.20
  • Revenue compounding 25% a year
  • Valuation is weak (0.0/10)
  • Expensive at 184× earnings
2 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Veerhealth Care Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.